top of page
Accelerating Drug Discovery
“The R2M team worked with Tenaya to accelerate lead optimization in our small molecule drug development programs. R2M was a great resource for us a start-up biotech company without internal medicinal chemistry expertise. They supported target validation, compound optimization, DMPK and patent strategy needs in a very professional and efficient manner. R2M has an experienced, productive, and results-oriented team and are great to work with.”
Timothy Hoey, Ph.D.
Chief Scientific Officer
Tenaya Therapeutics, Inc.
bottom of page